1. Direct-to-consumer (DTC) prescription drugs ads encourage people to
seek medical advice from health professionals.
According to a 2004 FDA survey, 77% of people said DTC ads increased
awareness of new drugs and 58% thought the ads gave enough information
to help them decide whether to speak to a physician.
2. DTC prescription drug ads encourage patient compliance with treatment
81% doctors surveyed for a 2007 article published in Clinical Orthopaedics
and Related Research thought DTC prescription drug ads had a positive
impact on patient compliance.
3. DTC prescription drug ads help remove the stigma associated with certain
disease and medical conditions.
Ads for drugs treating mental illnesses like depression had contributed to
destigmatizing those conditions, which have helped patients get treatment.
4. DTC prescription drugs ads create revenue for drug companies, which can
be used for research & development (R&D) to create new life-changing drugs.
1. Direct-to-consumer (DTC) drug ads misinform patients:
According to a study published in the Sep.2013 issue of Journal of General
Internal Medicine, 60% of claims made in CTC prescription drug ads aired
from 2008 to 2010 “left out important information, exaggerated
information, provided opinions, or made meaningless associations with
2. Normal conditions and bodily functions are medicalized and stigmatized
by DTC prescription drug ads.
Normal attributes, such as thinner eyelashes, or normal aging processes,
such as lower testosterone and wrinkles, are medical conditions that need to
be treated with drugs.
3. DTC prescription drugs ads increase health care costs.
78% of doctors surveyed in 2013 agreed that DTC prescription drug ads
increased the cost of healthcare. 37% of doctors surveyed that they often
prescribed brand name drugs rather than prescribe the equivalent and
generic drug upon patient request.